SLC38A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.548400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.381000E-01
Normal-vs-Stage2
4.761400E-01
Normal-vs-Stage3
1.781840E-01
Normal-vs-Stage4
3.179200E-01
Stage1-vs-Stage2
7.009400E-01
Stage1-vs-Stage3
2.722600E-01
Stage1-vs-Stage4
2.915200E-01
Stage2-vs-Stage3
1.557770E-01
Stage2-vs-Stage4
1.903810E-01
Stage3-vs-Stage4
8.974600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.578600E-01
Normal-vs-AfricanAmerican
3.361600E-01
Normal-vs-Asian
4.093000E-01
Caucasian-vs-AfricanAmerican
6.794200E-01
Caucasian-vs-Asian
5.215200E-01
AfricanAmerican-vs-Asian
4.409800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.824000E-01
Normal-vs-Female
4.266800E-01
Male-vs-Female
1.922360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.566400E-01
Normal-vs-Age(41-60Yrs)
5.296000E-01
Normal-vs-Age(61-80Yrs)
4.221000E-01
Normal-vs-Age(81-100Yrs)
3.200800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.173640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.845000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.795800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.336200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.915400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.625400E-01
Normal-vs-Daily Drinker
3.645400E-01
Normal-vs-Weekly Drinker
3.648600E-01
Normal-vs-Occasional Drinker
1.834200E-01
Normal-vs-Social Drinker
5.746800E-01
Non Drinker-vs-Daily Drinker
1.114420E-01
Non Drinker-vs-Weekly Drinker
2.018800E-01
Non Drinker-vs-Occasional Drinker
7.531800E-01
Non Drinker-vs-Social Drinker
2.905200E-01
Daily Drinker-vs-Weekly Drinker
9.455000E-01
Daily Drinker-vs-Occasional Drinker
1.547760E-01
Daily Drinker-vs-Social Drinker
2.407900E-02
Weekly Drinker-vs-Occasional Drinker
2.325400E-01
Weekly Drinker-vs-Social Drinker
7.986400E-02
Occasional Drinker-vs-Social Drinker
5.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.200200E-02
Normal-vs-Grade 2
3.476300E-02
Normal-vs-Grade 3
3.276500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.290400E-01
Grade 1-vs-Grade 3
3.842800E-01
Grade 1-vs-Grade 4
8.200200E-02
Grade 2-vs-Grade 3
1.749240E-01
Grade 2-vs-Grade 4
3.476300E-02
Grade 3-vs-Grade 4
3.276500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.573600E-01
Normal-vs-NonDiabetic
4.304400E-01
Diabetic-vs-NonDiabetic
6.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.790000E-01
Normal-vs-NoPancreatitis
4.328200E-01
Pancreatitis-vs-NoPancreatitis
6.331000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.279600E-01
Normal-vs-N1
4.735800E-01
N0-vs-N1
2.697400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.533600E-01
Normal-vs-TP53-NonMutant
5.685800E-01
TP53-Mutant-vs-TP53-NonMutant
2.615600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
